Diffuse foot process effacement in IgA nephropathy: MCD-Like versus non-MCD-like phenotypes and response to corticosteroid-based immunosuppression [0.03%]
IgA肾病中弥漫性足细胞变平的MCD样与非MCD样表型及其对以糖皮质激素为基础免疫抑制治疗的反应差异研究
Xiaoli Wen,Yang Yang,Fang Zeng et al.
Xiaoli Wen et al.
Background and hypothesis: Diffuse foot process effacement (FPE) is an ultrastructural associated with severe proteinuria and adverse renal outcomes in IgA nephropathy (IgAN). Among IgAN patients with diffuse FPE, light-m...
KDIGO 2025 Clinical Practice Guideline for ADPKD: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney [0.03%]
从ERA基因与肾脏工作组视角对KDIGO 2025 ADPKD临床实践指南中颅内动脉瘤及其他血管表现的解读
Melanie M Y Chan,Tom Nijenhuis,Flavia Galletti et al.
Melanie M Y Chan et al.
The 2025 KDIGO Clinical Practice Guideline for Autosomal Dominant Polycystic Kidney Disease (ADPKD) addresses intracranial aneurysms (ICAs) and other vascular manifestations, an aspect of ADPKD care which is of considerable clinical importa...
KDM1A regulates nephron progenitor programs and is associated with human kidney disease risk [0.03%]
KDM1A调控 nephron 干细胞程序并与人类肾脏疾病风险相关
Lakshmi P Kolligundla,Dhanunjay Mukhi,Jonathan Levinsohn et al.
Lakshmi P Kolligundla et al.
Background: Genome-wide association studies (GWAS) have identified numerous loci associated with kidney function, but linking non-coding variants to causal effector genes remains challenging. By integrating fine-mapped GW...
Bayesian Methods in Nephrology: Applications in Adaptive Trials, Dynamic Risk Prediction, Pharmacokinetics, and Causal Inference [0.03%]
肾脏病学中的贝叶斯方法:自适应试验、动态风险预测、药代动力学和因果推理中的应用
Concetto Sessa,Wisit Cheungpasitporn,Ionut Nistor et al.
Concetto Sessa et al.
Bayesian statistics is gaining momentum in biomedical research, offering a flexible and intuitive framework for integrating prior knowledge, managing uncertainty, and informing decision-making. In nephrology, a field marked by complex patho...
Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials [0.03%]
基于临床试验的尿白蛋白肌酐比和尿蛋白肌酐比与肾功能衰竭相关性的汇总分析
Maaike Mepschen,Remon Vos,William Herrington et al.
Maaike Mepschen et al.
Background and hypothesis: Urinary albumin-to-creatinine ratio (UACR) and urinary protein-to-creatinine ratio (UPCR) are widely used markers for chronic kidney disease (CKD) risk stratification. While albuminuria is consi...
Recommendations for Pre-Analytical Urine Sample Handling To Allow Optimal Assessment of Albuminuria and Proteinuria A consensus report of the USA NKF Albuminuria - Proteinuria Workshop [0.03%]
尿液样本处理以使尿白蛋白和蛋白检测效果最大化:预分析阶段的处理建议——美国肾脏病学会白蛋白/蛋白尿 workshop 共识报告
Stefan Ridderbos,Dominique van Mil,Bengt Fellström et al.
Stefan Ridderbos et al.
Albuminuria and proteinuria are key biomarkers for diagnosing, staging, and monitoring of chronic kidney disease. Both are also strongly associated with renal and cardiovascular risk. Given their important diagnostic role, reliable measurem...
Marina de Cos,Mona Zeghal,Kristin Meliambro
Marina de Cos
Kidney organoids have emerged as powerful in vitro models for investigating normal kidney physiology, disease development, and drug screening, offering unique advantages over traditional cell culture and animal-based systems. By recapitulat...
Intestinal Barrier Dysfunction in Chronic Kidney Disease: Evidence, Mechanisms, and its Potential Clinical Implications [0.03%]
慢性肾脏病肠道屏障功能障碍:证据、机制及潜在临床意义
Ward Zadora,Elisabeth Jacobs,Mara Lauriola et al.
Ward Zadora et al.
Methods: The gut-kidney axis plays a critical role in chronic kidney disease (CKD), with evidence suggesting that intestinal barrier dysfunction contributes to systemic inflammation and toxin accumulation. However, findin...
Diego Moriconi,Clara Garcia-Carro,Julio Nuñez et al.
Diego Moriconi et al.
The renin-angiotensin-aldosterone system (RAAS) plays a central role in regulating renal hemodynamics, sodium and water balance, and cardiovascular homeostasis. Chronic RAAS activation contributes to hypertension, proteinuria, inflammation,...